Stocks
Novo Nordisk (NVO) OCF US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| OCF | ? | 78 887 000 000 | 78 887 000 000 | 108 908 000 000 | 120 968 000 000 | 119 102 000 000 | 118 595 000 000 | ||
| Changes by years, y/y, % | +43% | 0% | +38% | +11% | -2% | +18.0% | |||
Novo Nordisk. OCF
Novo Nordisk. OCF, changes, %
Novo Nordisk. OCF, sum by quarters
Novo Nordisk (NVO) OCF US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| OCF | ? | 24 591 000 000 | 40 785 000 000 | 46 107 000 000 | 7 619 000 000 | 24 084 000 000 | 118 595 000 000 | |
| Changes by years, y/y, % | +72% | -19% | -38% | -2% | ||||
| Changes by quarters, q/q, % | +100% | +66% | +13% | -83% | +216% | |||
